scispace - formally typeset
A

Anastasios Konstantinidis

Researcher at Medical University of Vienna

Publications -  61
Citations -  2676

Anastasios Konstantinidis is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Light therapy & Bipolar disorder. The author has an hindex of 23, co-authored 60 publications receiving 2151 citations. Previous affiliations of Anastasios Konstantinidis include Ludwig Maximilian University of Munich & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

Phil Lee, +606 more
- 12 Dec 2019 - 
TL;DR: Genetic influences on psychiatric disorders transcend diagnostic boundaries, suggesting substantial pleiotropy of contributing loci within genes that show heightened expression in the brain throughout the lifespan, beginning prenatally in the second trimester, and play prominent roles in neurodevelopmental processes.
Journal ArticleDOI

Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome

Alden Y. Huang, +79 more
- 21 Jun 2017 - 
TL;DR: An enrichment of global CNV burden that was prominent for large (> 1 Mb), singleton events and known, pathogenic CNVs is observed, indicating that rare structural variation contributes significantly to the genetic architecture of TS.
Journal ArticleDOI

A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder.

TL;DR: Genotype distribution and allele frequencies were strongly associated with DSM-IV depression subtypes and are compatible with the hypothesis of a disease process that is not causally related to 5-HTTLPR, but involves5-HT neurotransmission and 5- HTTLPR somewhere on its way to phenotypic disease expression.
Journal ArticleDOI

Agomelatine in the treatment of seasonal affective disorder.

TL;DR: The results of this study suggest that seasonal depression may be effectively and safely treated with agomelatine.